A randomised, double-blind, placebo-controlled, phase III trial to study the effect of irbesartan on endothelial function of the retinal vasculature in patients with hypercholesterolemia
Latest Information Update: 13 Jul 2023
At a glance
- Drugs Irbesartan (Primary)
- Indications Cerebral ischaemia; Hypercholesterolaemia
- Focus Pharmacodynamics
- 01 Nov 2016 Results assessing effect of Valsartan on retinal capillary rarefaction in hypertensive patients (n=150) using patients data from this and other two trials (NCT01318395 and NCT01319344) published in the Journal of Clinical Hypertension (Greenwich)
- 03 Feb 2010 Actual initiation date (Nov 2009) added as reported by ClinicalTrials.gov
- 19 Jan 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.